CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 34,671	$ 29,922
Grant receivables	861	1,281
Prepaid expenses and other current assets	2,436	3,019
Total current assets	37,968	34,222
Property and equipment, net	257	284
Right-of-use assets, operating leases	626	657
Total assets	38,851	35,163
Current liabilities:
Accounts payable	2,639	3,695
Accrued expenses	4,734	4,055
Deferred grant income, current	1,584	1,701
Operating lease liabilities, current	180	174
Other current liabilities	366	544
Total current liabilities	9,503	10,169
Operating lease liabilities, noncurrent	488	520
Deferred grant income and other liabilities, noncurrent	0	0
Total liabilities	9,991	10,689
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2024 and December 31, 2023
Common stock, $0.001 par value, 250,000,000 shares authorized; 39,985,866 and 32,165,478 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	40	32
Additional paid-in capital	179,160	165,826
Accumulated deficit	(150,340)	(141,189)
Accumulated other comprehensive loss		(195)
Total stockholders' equity	28,860	24,474
Total liabilities and stockholders' equity	$ 38,851	$ 35,163

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).